doramectin
zhejiang hisun pharmaceutical co., ltd - doramectin - unknown - doramectin anthelmintic active 0.0 - active constituent
milbemycin oxime
zhejiang hisun pharmaceutical co., ltd - milbemycin oxime - unknown - milbemycin oxime antibiotic active 0.0 - active constituent
paroxetine- paroxetine hydrochloride hemihydrate tablet, film coated paroxetine tablet, film coated
ncs healthcare of ky, llc dba vangard labs - paroxetine hydrochloride (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paroxetine 20 mg - major depressive disorder: paroxetine tablets are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology: clinical trials). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets in hospitalized depressed patients have not been adequately studied.
ceftriaxon 1 g pulbere pentru soluţie injectabilă
farmina srl Îcs - ceftriaxonum - pulbere pentru soluţie injectabilă - 1 g
ademetionină 500 mg pulbere şi solvent pentru soluţie injectabilă
farmina srl Îcs - ademetioninum - pulbere şi solvent pentru soluţie injectabilă - 500 mg
piracetam injection dung dịch tiêm
young-il pharm. co., ltd - piracetam - dung dịch tiêm - 1g/5ml
glucose 10%, 10 g, solution pour perfusion intraveineuse, flacon de 500 ml
prost pharma (france) co ltd - glucose anhydre - solution pour perfusion intraveineuse - 10 g
ringer lactate, 0,32g/0,6g/0,04g/0,027g, solution pour perfusion intraveineuse, flacon de 500 ml
prost pharma (france) co ltd - sodium lactate ringer's injection - solution pour perfusion intraveineuse - 0,32g/0,6g/0,04g/0,027g
sodium chloride injection 0.9%, 0.9g, solution pour perfusion intraveineuse, flacon de 500ml
prost pharma (france) co ltd - sodium chloride injection 0.9% 500ml - solution pour perfusion intraveineuse - 0.9g
lovir
douglas pharmaceuticals limited - aciclovir 200mg; - dispersible tablet - 200 mg - active: aciclovir 200mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water sodium starch glycolate - · treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. · suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. · prophylaxis of herpes simplex infections in immune-competent patients. · treatment of acute herpes zoster (shingles) infections, for the reduction of the duration and severity of acute symptoms and rash, for the reduction of all zoster associated pain and for the reduction of the incidence and duration of postherpetic neuralgia. · management of patients with severe aids who have a cd4 count of less than 50/µl. studies have shown that oral aciclovir given in conjunction with antiretroviral therapy reduced mortality in patients with advanced hiv disease. · patients undergoing allogenic bone marrow transplantation who are at risk of developing cmv infection while immunosuppressed (preceded by one month's treatment with intravenous aciclovir). studies have shown that oral aciclovir reduced mortality in allogenic bone marrow transplant recipients. in addition oral aciclovir provided effective prophylaxis for herpes virus disease.